SK bioscience Co.,Ltd. (KRX: 302440)
South Korea
· Delayed Price · Currency is KRW
44,850
+150 (0.34%)
Nov 18, 2024, 3:30 PM KST
SK bioscience Co.,Ltd. Revenue
SK bioscience Co.,Ltd. had revenue of 26.78B KRW in the quarter ending June 30, 2024, with 1.13% growth. This brings the company's revenue in the last twelve months to 371.48B, up 33.42% year-over-year. In the year 2023, SK bioscience Co.,Ltd. had annual revenue of 369.51B, down -19.10%.
Revenue (ttm)
371.48B
Revenue Growth
+33.42%
P/S Ratio
9.27
Revenue / Employee
377.52M
Employees
984
Market Cap
3,513.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 369.51B | -87.22B | -19.10% |
Dec 31, 2022 | 456.73B | -472.28B | -50.84% |
Dec 31, 2021 | 929.00B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition